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Sotalol (SOT), (RS)-N-{4-[1-hydroxy-2-
(propan-2-ylamino)ethyl]phenyl} methanesulfon-
amide (Fig. 1A), is a nonselective antagonist of β-
adrenergic receptors. It has β-adrenolytic activity,
prolongs the repolarization of the heart. Sotalol
strongly acts in ventricular arrhythmias, less in the
termination of atrial fibrillation and atrial flutter.
Due to the fact that it lengthens the duration of
action potential and repolarization of cardiac cells, it
belongs to the group of antiarrhythmic drugs. It
reduces the risk of recurrent myocardial infarction,
without affecting mortality.
Oxprenolol (OXP), (RS)-1-[2-(allyloxy)phe-
noxy]-3-(isopropylamino)propan-2-ol (Fig. 1B),
belongs to the group of non-selective β-blockers. It
has medium sympathomimetic activity. Oxprenolol
is safe when used in ischemic heart disease accom-
panied by heart failure due to its intrinsic activity, it
slows the heart rate, reduces oxygen demand, and
improves exercise tolerance. It is mainly used in
patients with hypertension, ischemic heart disease,
as well as in acute myocardial infarction.
Labetalol (LAB), (RS)-2-hydroxy-5-{1-hydr-
oxy-2-[(1-methyl-3-phenylpropyl)amino] ethyl}
benzamide (Fig. 1C), is a competitive antagonist of
α1 and β receptors. Blocking the receptor α1 caus-
es smooth muscle relaxation and dilation of the
arteries, and that is why labetalol is mainly used to
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Abstract: The usefulness of derivative spectrophotometry for the determination of labetalol, sotalol and
oxprenolol in binary mixtures and in human spiked serum was checked. To this aim a spectrophotometric analy-
sis of samples in the UV range was carried out and the obtained results revealed that derivative spectropho-
tometry allows for the fast, accurate and precise determination of the tested substances in spite of their clear
interference in the zero-order spectra. For quantitative determinations ìzero-crossingî technique was used to
establish wavelengths for zeros of specified component. In a mixture of labetalol and oxprenolol the following
wavelengths were established: D1 λ = 245.32 nm and 266.03 nm, D2 λ = 243.30 nm and 301.09 nm. respec-
tively. D3 derivative did not show zeros suitable for quantitative analysis. For the analysis of labetalol and
sotalol mixture, D3 derivative spectrophotometry was used at the following wavelengths: λ = 246.03 nm and λ
= 249.91 nm, respectively. In this case, the curves of D1 and D2 derivatives showed no zeros that can be used
in quantitative analysis. To determine the concentration of the components in a mixture containing oxprenolol
and sotalol the following wavelengths were selected: for oxprenolol D1 λ = 245.32 nm, D2 λ = 240.18 nm, D3
λ = 232.05 nm and for sotalol D1 λ = 230.56 nm, D2 λ = 232.65 nm and D3 λ = 238.84 nm, respectively. The
developed spectrophotometric method was characterized by high sensitivity and accuracy, LOD determined for
sotalol was in the range of 0.21-1.88 µg/mL, for labetalol 1.00-3.43 µg/mL and for oxprenolol 0.16-2.06
µg/mL; LOQ determined for sotalol was in the range of 0.65-5.70 µg/mL, for labetalol 3.11-10.39 µg/mL and
for oxprenolol 0.47-6.23 µg/mL, depending on the composition of the tested mixture and the order of the deriv-
ative. The recovery of the individual components was within the range of 100 ± 5%. The linearity range was
wide and estimated for sotalol in the range of 11.00-38.50 µg/mL, for labetalol 12.80-44.80 µg/mL and for
oxprenolol 12.60-44.10 µg/mL with correlation coefficients in the range of 0.9977-0.9999.
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lower blood pressure. It is recommended in cases
where hypertension occurs in conjunction with coro-
nary heart disease and with increased plasma renin
activity (1, 2). 
Due to the extensive use of drugs from the
group of β-blockers in the treatment of hypertension
and other cardiovascular diseases, there are many
studies on the analysis of this class of drugs avail-
able in the literature. They are mostly based on sep-
aration methods such as thin-layer chromatography
(TLC), high-performance liquid chromatography
(HPLC), liquid chromatography (LC) and gas chro-
matography (GC) (3-7). For the determination of
sotalol and other β-blockers in serum and urine LC-
MS method or capillary electrophoresis (CE) with
amperometric detection were used (8). These drugs
may appear in different enantiomeric forms that can
vary in pharmacological activity and toxicity and for
their analysis RP-LC (reversed-phase liquid chro-
matography) (9) and methods based on capillary
electrophoresis were used (10-13).
The use of β-blockers in sport as substances
enhancing physical fitness has led to the need for the
application of analytical methods in antidoping con-
trol (14, 15).
In the comprehensive analysis of selected sub-
stances of this group, spectrophotometric method
was used, in which chemometric methods were
applied to eliminate the interferences in spectra of
tested substances (16). Spectrophotometric methods
are found to be preferable instead of hyphenated
analytical instrumentations or techniques such as
LC/MS and GC/MS due to the fast quantitative res-
olution of samples containing two or more sub-
stances without needing any special chemical pre-
treatment. In our previous studies, we have applied
a derivative spectrophotometric method for the
determination of other substances from group of
hypotensive drugs in their mixtures, in the presence
of substances having an influence on the proper
function of cardiovascular system (17-19).
The widespread use of drugs from the group of
β-blockers led the authors to develop a direct, rapid
and accurate derivative spectrophotometric method
for the determination of SOT, OXP and LAB both in
mixtures and in biological material. 
Figure 1. Chemical structure (A) sotalol (SOT), (B) oxprenolol (OXP) and (C) labetalol (LAB)
Figure 2. Zero-order absorption spectra of LAB (1- c = 38.4 mg/mL), SOT (2 - c = 38.4 mg/mL) and OXP (3 - c = 44.1 mg/mL)
A B C
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EXPERIMENTAL
Instruments
Spectrophotometer UV-VIS Cary 100 (Varian),
quartz cuvettes (l = 1 cm). Computer Dell Optiplex
755; Intel(R) Core(TM)2 Duo CPU; E4500 @ 2.20
GHz; 1.18 GHz, 1.95 GB Ram (Microsoft Office
2010, Statistica 10, edition 2012).
Chemicals
Reference standards: 
Sotalol hydrochloride ñ European Pharmaco-
poeia (EP) Reference Standard oxprenolol hydro-
chloride ñ European Pharmacopoeia (EP) Reference
Standard, labetalol hydrochloride ñ European
Pharmacopoeia (EP) Reference Standard (all from
Fluka). Reagents of analytical grade quality:
methanol. Human serum was obtained by courtesy of
the Regional Blood Transfusion Center in KrakÛw.
Procedures
Standard and working solution
SOT - to a 10.0 mL volumetric flask 5.5 mg of
sotalol hydrochloride was weighed using analytical
balance, and filled with methanol to a specified vol-
ume.
Figure 3. The first (D1) and second (D2) derivative values for standard solutions of LAB (-) and OXP(óó)
Figure 4. The third (D3) derivative values for standard solutions of LAB (-) and SOT(óó).
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OXP - to a 10.0 mL volumetric flask
6.3 mg of oxprenolol hydrochloride was
weighed using analytical balance, and filled
with methanol to a specified volume.
LAB - to a 10.0 mL volumetric flask
6.4 mg of labetalol hydrochloride was
weighed using analytical balance, and filled
with methanol to a specified volume.
For direct measurements, standard
solutions were diluted with methanol in a 5.0
mL volumetric flask, to obtain working solu-
tions at a concentrations in the range from
11.00 to 38.50 µg/mL for SOT, from 12.60
to 44.10 µg/mL for OXP and from 12.80 to
44.80 µg/mL for LAB.
Spectral characteristics of SOT, OXP and
LAB
In the first stage of the study, absorp-
tion spectra of the standard solutions of SOT
(38.50 µg/mL), OXP (44.10 µg/mL) and
LAB (38.40 µg/mL) were recorded in quartz
cuvettes (l = 1 cm), using methanol as a ref-
erence solution in the UV range. The regis-
tered spectra were characterized by a not
very specific course and clear interference
was observed in the range 215-290 nm.
Analysis of the spectra led to the conclusion
that the direct determination of the tested
substances, based on zero-order absorption
spectra is much more difficult, and thus
results obtained in this way because of the
interference may be burdened with a signifi-
cant error (Fig. 2).
Conversion of zero-order spectra into
derivatives caused their significant variation.
Applying Ñzero-crossingî technique allowed
to determine the wavelengths that were used
for quantitative analysis of the individual
components of the tested mixtures. For a
mixture of LAB and OXP the first derivative
of the spectrum (D1) and the second deriva-
tive of the spectrum (D2) were useful for
quantitative analysis. For the determination
of LAB the following wavelengths were
used D1 λ = 245.32 nm, and D2 λ = 243.30,
whereas OXP was determined at D1 λ =
266.03 and D2 λ = 301.09 nm (Fig. 3).
Quantitative determination of LAB and
SOT in a binary mixture was possible only
by using the third derivative of the absorp-
tion spectrum (D3), and the selected wave-
lengths were λ = 249.91 nm for SOT and λ
= 246.03 nm for LAB (Fig. 4).
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Quantitative determinations of the mixture
composed of OXP and SOT were carried out using
the D1, D2 and D3 derivatives at wavelengths: for
SOT D1 λ = 230.56 nm, D2 λ = 232.56 nm and D3
λ = 238.84 nm, while for OXP D1 λ = 245.32 nm,
D2 λ = 240.18 and D3 λ = 232.05 nm, respectively
(Fig. 5).
Method validation
The validation was done according to ICH rec-
ommendations for linearity, range, accuracy and
precision, limit of detection (LOD), limit of quan-
tification (LOQ) and relative recovery (20).
Figure 5. The first (D1), second (D2) and third (D3) derivative values for standard solutions of SOT (-) and OXP (óó).
Table 2. Validation parameters of the proposed spectrophotometric methods for the determination of labetalol.
Labetalol hydrochloride
Parameters D1 λ = 245.32 nm) D2 (λ = 243.30 nm) D3 (λ = 246.03 nm)
Linearity range [ g/mL] 12.80 - 44.80
Regression equation y = 0.0014x + 0.0018 y = 0.0001x - 0.2∑10-5 y = 0.00002x + 0.4∑10-4
Correlation coefficient (r) 0.9979 0.9999 0.9977
Durbin-Watson test 1.278 1.647 1.317
Lagrange'a test (p) 3.188 (0.074) - 3.474 (0.062)
Shapiro-Wilk test (p) 0.973 (0.910) 0.837 (0.122) 0.967 (0.871)
Mandel's test (p) 1.797 (0.272) 1.328 (0.333) 1.995 (0.253)
LOD [ g/mL] 2.76 1.00 3.43
LOQ [ g/mL] 8.37 3.11 10.39
Accuracya [%] 100.25 ± 1.70 98.52 ± 1.14 100.87 ± 1.98
Precisionb [%] 99.75 99.57 101.35
RSD% 1.69 1.16 1.97
a) Three concentrations of each analyte (20.48, 25.60, 30.72 µg/mL), repeated three times for each concentrate. b) Three concentrations of
each analyte (12.80, 25.60, 38.40 µg/mL), repeated three times for each concentrate.
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Linearity
Zero-order absorption spectra
were registered for methanol solutions
of SOT in the range of 11.0-38.5
µg/mL, for OXP in the range of 12.6-
44.1 µg/mL and for LAB from 12.8 to
44.8 µg/mL. After conversion of the
absorption spectra into the D1, D2 and
D3 curves of derivative, the value of
derivative was read at an appointed
wavelength. The graph of D1; 2; 3 =
f(c) was plotted. In the tested concen-
tration ranges, linearity was main-
tained for all chosen wavelengths. To
evaluate the results, linear regression
equation characterizing the intersec-
tion points, correlation coefficients,
Mandelís, Shapiro-Wilk, the Durbin-
Watson and Lagrange tests were used.
In the evaluation of the calibration
method, linear and quadratic fit were
tested. Both models were compared
using Mandelís test. The p-value < 0.05
indicates an equivalence of both fits.
Normal distribution of the residuals was
tested by the Shapiro-Wilk test. The
value of W greater than the critical
value allows to assume normal distribu-
tion. By using Durbin-Watson test, the
presence of residual autocorrelation
was checked. If the tested values of DW
are greater than the upper critical value,
no significant autocorrelation is
observed, and if the DW values are
lower than the lower critical value, then
autocorrelation appears. The test does
not give an answer on the occurrence of
autocorrelation, when DW is in the
range between the lower and upper crit-
ical value and in such case, the applica-
tion of Lagrange test is recommended. 
Accuracy and precision 
The accuracy of the method was
determined as a percentage of analyte
recovery for the prepared solutions at
three concentration levels: 80, 100 and
120%.
The precision of the method was
checked using the proposed procedure
for the determination of solutions con-
taining very specific analyte amounts
at three concentration levels: 50, 100
and 150%. 
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All measurements were repeated three times,
accuracy and precision of the results were calculat-
ed using the appropriate regression equation.
Limit of detection (LOD) and limit of quantitation
(LOQ) 
LOD and LOQ were determined using stan-
dard error of the estimate (SY) and the slope of the
calibration curve (a) and calculated according to the
formulas:
LOD = 3.3∑SY/a and LOQ = 10.0∑SY/a. 
Laboratory prepared mixtures containing different
ratios of SOT, LAB and OXP (Selectivity)
To a series of 5.0 mL volumetric flasks, dif-
ferent amounts of working solutions were accu-
rately transferred and filled with methanol to a
specified volume, obtaining the following mix-
tures: SOT-LAB, SOT-OXP and LAB-OXP at
concentrations of 17.60, 22.00 and 26.40 µg/mL
for SOT, 20.48, 25.60 and 30.72 µg/mL for LAB
and 20.16, 25.20 and 30.24 µg/mL for OXP,
respectively. For such binary mixtures of the
active compounds, absorption spectra in the range
200-400 nm were recorded. After converting spec-
tra into derivatives of an appropriate order, the
values of derivatives against experimentally deter-
mined wavelengths were read. The amount of
determined compound was calculated using an
appropriate regression equation. Results along
with the statistical evaluation are shown in Tables
1-3. 
Table 4. Determination of the two analytes in laboratory prepared mixtures by the proposed spectrophotometric methods.
SOT OXP
Conc
. (Recovery% ± Sx)[µg/mL]
D1 D2  D3  D1  D2 D3
SOT OXP
102.43 ± 2.03 101.10 ± 0.77 102.52 ± 1.95 102.25 ± 0.77 100.62 ± 1.72 102.08 ± 4.86
24.20 16.38 t0.95 = ± 3.23 t0.95 = ± 1.22 t0.95 = ± 3.10 t0.95 = ± 2.97 t0.95 = ± 2.73 t0.95 = ± 7.73
RSD = 1.98% RSD = 0.76% RSD = 1.90% RSD = 1.89% RSD = 1.70% RSD = 4.76%
102.15 ± 2.59 102.53 ± 2.83 101.83 ± 2.97 103.47 ± 1.52 104.85 ± 1.18 106.50 ± 1.00
19.80 22.68 t0.95 = ± 4.13 t0.95 = ± 4.50 t0.95 = ± 4.73 t0.95 = ± 2.42 t0.95 = ± 1.88 t0.95 = ± 1.55
RSD = 2.53% RSD = 2.75% RSD = 2.91% RSD = 1.47% RSD = 1.12% RSD = 0.94%
17.60 32.76 100,88 ± 0,53 100.98 ± 2.85 103.06 ± 0.65 103.45 ± 1.36 102.07 ± 1.31 102.83 ± 1.07
t0.95 = ± 0.85 t0.95 = ± 4.53 t0.95 = ± 1.05 t0.95 = ± 2.16 t0.95 = ± 2.08 t0.95 = ± 1.70
RSD = 0.52% RSD = 2.18% RSD = 0.63% RSD = 1.31% RSD = 1.28% RSD = 1.04%
SOT LAB
SOT LAB
101.30 ± 1.78 100.43 ± 2.66
14.30 28.16 t0.95 = ± 2.83 t0.95 = ± 4.24
RSD = 1.75%  RSD = 2.65% 
102.83 ± 1.35 98.32 ± 0.68
19.80 23.04 t0.95 = ± 2.11 t0.95 = ± 0.90
RSD = 1.31%  RSD = 0.69%
104.28 ± 1.24 95.52 ± 1.63
28.60 20.48 t0.95 = ± 1.97 t0.95 = ± 2.60
RSD = 1.19%  RSD = 1.70% 
LAB OXP
LAB OXP
99.66 ± 2.76 99.60 ± 4.27 99.76 ± 1.99 99.63 ± 1.88
16.64 27.72 t0.95 = ± 4.36 t0.95 = ± 6.71 t0.95 = ± 3.18 t0.95 = ± 3.00
RSD = 2.76% RSD = 4.28% RSD = 2.00% RSD = 1.88%
102.25 ± 1.84 100.88 ± 2.18 105.00 ± 1.02 103.20 ± 3.08
23.04 22.68 t0.95 = ± 2.94 t0.95 = ± 3.48 t0.95 = ± 1.40 t0.95 = ± 4.90
RSD = 1.80% RSD = 2.16% RSD = 0.97% RSD = 2.98%
102.95 ± 1.00 100.87 ± 0.92 101.88 ± 2.54 101.15 ± 1.77
33.28 20.16 t0.95 = ± 1.55 t0.95 = ± 1.45 t0.95 = ± 4.04 t0.95 = ± 2.78
RSD = 0.97% RSD = 0.91% RSD = 2.45% RSD = 1.75%
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Preparation of real samples
Laboratory prepared mixtures
To a series of 5.0 mL volumetric flasks, appro-
priate amounts of standard solutions of examined
substances were measured to obtain concentrations
of components in the mixture corresponding to the
ratio of 1 : 2, 1 : 1 and 2 : 1 and within the linearity
range of calibration curve for the appropriate sub-
stance. 
Human serum
To 2.0 mL Eppendorf tubes, 400 µL of human
serum was added and the appropriate volume (50-
125 µL) of standard solutions of examined drugs
was measured to form binary mixtures at a given
concentration of the determined substance that were
vortexed for 1 min. To the prepared samples
methanol was added so that the total volume of the
mixture was 1.5 mL, and the mixture was vortexed
for 3 min. After that, the mixture was centrifuged
(10000 rpm for 5 min., temp. 22OC). From each tube
500 µL of the supernatant was transferred to a series
of 5.0 mL flasks and filled with methanol to the
specified volume. For the samples prepared in this
way, absorption spectra in the range 200-400 nm
were recorded using blank prepared in the same way
as sample solutions but without standard solutions.
After converting obtained spectra into derivatives of
an appropriate order, the values of derivatives
against experimentally determined wavelengths
were read. The concentration of the determined
compound in the examined mixture was calculated
using an appropriate regression equation. Results
along with the statistical evaluation are shown in
Tables 4, 5. 
DISCUSSION 
Hypertension is a growing medical problem
worldwide. With an increasing number of people
suffering from hypertension every year, the use of
antihypertensive drugs such as β-blockers increases.
The paper presents a procedure for the simultaneous
determination of drugs from this class by derivative
spectrophotometry. A characteristic feature of this
method is its simplicity, speed, and the possibility of
elimination of the interactions between determined
substances and their influence on the determination
results. In general, it was found that the proposed
procedure enables the determination of substances
from the group of β-blockers with satisfactory accu-
racy and precision both in pharmaceutical prepara-
tions and in the presence of human serum. The fact
that the absorption spectra of the tested substances
interfere with each other, causes that direct spec-
trophotometric analysis is impossible. It seems that
the above-mentioned difficulties are the reason for
replacing the spectrophotometric method by separa-
tion methods, which is justified in many cases.
Taking into account the advantages of the
spectrophotometric method such as simple way of
performing measurements, accuracy and availability
as well as progress in the production of modern
apparatus, we were able to demonstrate that this
method has still a wide range of applications in fast
and accurate quantitative analysis. New computa-
tional techniques create the potential for wider
application of spectrophotometry, the application of
derivatives of the zero-order spectra increases selec-
tivity and sensitivity of analyses in comparison with
the classical zero-order spectrophotometry. 
Conducted measurements indicate, that the
application of derivative spectrophotometry and
conversion of spectra into first, second and third
order derivatives, for the determination of sotalol,
labetalol and oxprenolol, enable the simultaneous
analysis of active compounds in binary mixtures and
in human spiked serum. 
Considering selected wavelengths, determined
by the ëzero-crossingí method, it was demonstrated
that the method is specific for the analyte, that is,
tested compounds. 
Quantitative determination carried out in mix-
tures and in the spiked serum was possible with the
application of a corresponding order of the derivative,
and so in case of the mixture OXP and LAB optimal
results were obtained using D1 and D2 derivatives.
For the quantitative determination of the mixture
composed of OXP and SOT, D1-D3 derivatives may
be used. If SOT and LAB were present in the sample,
curves of derivatives limited the possibility of using
only D3 derivative. No interference of matrix compo-
nents was observed, which demonstrates a good
selectivity of the method. The linearity was main-
tained over a wide range of concentrations between
11.00 and 38.50 µg/mL for sotalol, between 12.80
and 44.80 µg/mL for labetalol, and between 12.60
and 44.10 µg/mL for oxprenolol. The value of corre-
lation coefficient R in the range of 0.9977ñ0.9999 did
not specify clearly the linearity of calibration method.
Therefore, to evaluate the linearity, Mandelís test was
used. The obtained results of linear and quadratic fit,
indicated a linear fit of the calibration curves in most
cases, except for oxprenolol D2 240.18 nm and
sotalol D1 320.56 nm where quadratic fit was chosen.
The normality of distribution of residuals was con-
firmed by the Shapiro-Wilk test. The points of line
intersection of the appropriate curves did not signifi-
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cantly differ from zero. The results of the analysis of
the Durbin-Watson test showed no significant auto-
correlation of random components of calibration
curves for OXP D1 245.43 nm, D1 266.03 nm, D3
232.05 nm, LAB D2 243.30 nm, SOT D1 230.56 nm,
D2 232.65, D3 238.84 and D3 249.91 nm. In the case
of OXP D2 240.18 nm, D2 301.09 nm, LAB D1
245.32 nm and D3 246.03 nm, the Lagrange test was
used, as the Durbin-Watson test was not conclusive.
In the linear alignment for OXP D2 301.09 nm, neg-
ative autocorrelation was found, however it was
decided to apply the least squares method, accepting
less efficiency of estimators.
The sensitivity of the developed method was
high, LOD values for particular substances were
estimated at 0.21-1.88 µg/mL for sotalol, 1.00-3.43
µg/mL for labetalol and 0.16-2.06 µg/mL for
oxprenolol, whereas LOQ values were estimated at
0.65-5.70 µg/mL for sotalol, 3.11-10.39 µg/mL for
labetalol and 0.47-6.23 µg/mL for oxprenolol
depending on the composition of the mixture and on
the class of derivative. Percent of the recovery of
tested compounds presented as the average values
for the three concentration levels was high and was
in the range of 100 ± 5%. All validation parameters
are summarized in Tables 1-3. The results of the
measurements for particular active compounds both
in mixtures and in spiked human serum did not dif-
fer from the declared values, they were character-
ized by good precision and accuracy, as evidenced
by Sx - standard deviation, t0.95% - confidence inter-
val and RSD - relative standard deviation presented
in Tables 4 and 5.
CONCLUSION
Proposed derivative spectrophotometric
method is useful for the direct determination of
sotalol, labetalol and oxprenolol both in binary mix-
tures and in spiked human serum. The application of
Ñzero-crossingî technique allowed for the determi-
nation of the appropriate wavelengths, at which no
interference of determined analytes was observed.
The proposed method is precise, accurate and spe-
cific under experimental conditions. It can be used
for routine determinations of tested substances as an
alternative to time consuming and expensive separa-
tion techniques. 
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